2
Clinical Trials associated with Therapeutic autologous dendritic cells(Institut Jean Paoli & Irene Calmettes)Pilot Study of Therapeutic Vaccination by Leukemic Blasts in Vitro Differentiated Dendritic Cells From Patients With Acute Myelogenous Leukemia in Complete Remission
RATIONALE: Vaccines made from dendritic cells may help the body build an effective immune response to kill cancer cells.
PURPOSE: This phase I trial is studying the side effects of vaccine therapy and to see how well it works in treating patients with acute myeloid leukemia in complete remission.
/ Unknown statusPhase 1/2IIT Vaccination of Stage IV Cutaneous Melanoma Patients With Mature, Autologous Monocyte-Derived Dendritic Cells Transfected With Unselected Autologous Amplified Tumor-RNA
RATIONALE: Vaccines made from a person's tumor cells and white blood cells may help the body build an effective immune response to kill tumor cells.
PURPOSE: This phase I/II trial is studying the side effects of vaccine therapy and to see how well it works in treating patients with stage IV melanoma.
Start Date01 Apr 2005 |
Sponsor / Collaborator- |
100 Clinical Results associated with Therapeutic autologous dendritic cells(Institut Jean Paoli & Irene Calmettes)
100 Translational Medicine associated with Therapeutic autologous dendritic cells(Institut Jean Paoli & Irene Calmettes)
100 Patents (Medical) associated with Therapeutic autologous dendritic cells(Institut Jean Paoli & Irene Calmettes)
100 Deals associated with Therapeutic autologous dendritic cells(Institut Jean Paoli & Irene Calmettes)